Atara Biotherapeutics (ATRA) EBITDA Margin Growth (3y) (2024 - 2026)
Atara Biotherapeutics (ATRA) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | -2,649.00 |
| 10 | Atara Biotherapeutics | 143.49 Mn | 126.94 Mn | 439,000.00 | 671,307.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 671,307.00 |
| Mar 31, 2026 | 783,329.00 |
| Dec 31, 2025 | 409,983.00 |
| Sep 30, 2025 | 179,428.00 |
| Jun 30, 2025 | 8,049.00 |
| Dec 31, 2024 | 120,020.00 |
| Sep 30, 2024 | 152,523.00 |
| Jun 30, 2024 | 210,694.00 |
| Mar 31, 2024 | 208,862.00 |